Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bernd Gerber

Showing results (81-90 of 173) with videos related to

Pageof 18
Sort By:
Hypertension in Pregnancy|December 6, 2013
miRNA expression profiles determined in maternal sera of patients with HELLP syndromeJohannes Stubert, Dirk Koczan, Dagmar-Ulrike Richter, et al.
Plastic and Reconstructive Surgery|June 29, 2013
Implant-based breast reconstruction using a titanium-coated polypropylene mesh (TiLOOP Bra): a multicenter study of 231 casesMax Dieterich, Stefan Paepke, Karin Zwiefel, et al.
Cancer|January 25, 2005
The persistence of isolated tumor cells in bone marrow from patients with breast carcinoma predicts an increased risk for recurrenceWolfgang Janni, Brigitte Rack, Christian Schindlbeck, et al.
International Journal of Clinical and Experimental Pathology|July 9, 2011
Toponostics of invasive ductal breast carcinoma: combination of spatial protein expression imaging and quantitative proteome signature analysisClaudia Röwer, Björn Ziems, Anngret Radtke, et al.
Skin Pharmacology and Physiology|January 24, 2015
Non-invasive spectroscopic determination of the antioxidative status of gravidae and neonatesHanne Lademann, Bernd Gerber, Dirk M Olbertz, et al.
Breast Cancer Research and Treatment|December 25, 2003
Patients with recurrent breast cancer: does the primary axillary lymph node status predict more aggressive tumor progression?Brigitte Rack, Wolfgang Janni, Bernd Gerber, et al.
Oncology Reports|February 12, 2005
Expression of glycodelin protein and mRNA in human ductal breast cancer carcinoma in situ, invasive ductal carcinomas, their lymph node and distant metastases, and ductal carcinomas with recurrenceUdo Jeschke, Ioannis Mylonas, Christiane Kunert-Keil, et al.
Journal of Cancer Research and Clinical Oncology|July 29, 2003
Intra-mammary tumor location does not influence prognosis but influences the prevalence of axillary lymph-node metastasesWolfgang Janni, Brigitte Rack, Harald Sommer, et al.
Analytical and Bioanalytical Chemistry|October 31, 2009
Towards a proteome signature for invasive ductal breast carcinoma derived from label-free nanoscale LC-MS protein expression profiling of tumorous and glandular tissueClaudia Röwer, Johannes P C Vissers, Cornelia Koy, et al.
Breast Cancer Research and Treatment|April 22, 2022
False-negative rate in the extended prospective TATTOO trial evaluating targeted axillary dissection by carbon tattooing in clinically node-positive breast cancer patients receiving neoadjuvant systemic therapyJana de Boniface, Jan Frisell, Thorsten Kühn, et al.
Pageof 18

Showing results (81-90 of 173) with videos related to

Sort By:
Pageof 18
Hypertension in Pregnancy|December 6, 2013
miRNA expression profiles determined in maternal sera of patients with HELLP syndromeJohannes Stubert, Dirk Koczan, Dagmar-Ulrike Richter, et al.
Plastic and Reconstructive Surgery|June 29, 2013
Implant-based breast reconstruction using a titanium-coated polypropylene mesh (TiLOOP Bra): a multicenter study of 231 casesMax Dieterich, Stefan Paepke, Karin Zwiefel, et al.
Cancer|January 25, 2005
The persistence of isolated tumor cells in bone marrow from patients with breast carcinoma predicts an increased risk for recurrenceWolfgang Janni, Brigitte Rack, Christian Schindlbeck, et al.
International Journal of Clinical and Experimental Pathology|July 9, 2011
Toponostics of invasive ductal breast carcinoma: combination of spatial protein expression imaging and quantitative proteome signature analysisClaudia Röwer, Björn Ziems, Anngret Radtke, et al.
Skin Pharmacology and Physiology|January 24, 2015
Non-invasive spectroscopic determination of the antioxidative status of gravidae and neonatesHanne Lademann, Bernd Gerber, Dirk M Olbertz, et al.
Breast Cancer Research and Treatment|December 25, 2003
Patients with recurrent breast cancer: does the primary axillary lymph node status predict more aggressive tumor progression?Brigitte Rack, Wolfgang Janni, Bernd Gerber, et al.
Oncology Reports|February 12, 2005
Expression of glycodelin protein and mRNA in human ductal breast cancer carcinoma in situ, invasive ductal carcinomas, their lymph node and distant metastases, and ductal carcinomas with recurrenceUdo Jeschke, Ioannis Mylonas, Christiane Kunert-Keil, et al.
Journal of Cancer Research and Clinical Oncology|July 29, 2003
Intra-mammary tumor location does not influence prognosis but influences the prevalence of axillary lymph-node metastasesWolfgang Janni, Brigitte Rack, Harald Sommer, et al.
Analytical and Bioanalytical Chemistry|October 31, 2009
Towards a proteome signature for invasive ductal breast carcinoma derived from label-free nanoscale LC-MS protein expression profiling of tumorous and glandular tissueClaudia Röwer, Johannes P C Vissers, Cornelia Koy, et al.
Breast Cancer Research and Treatment|April 22, 2022
False-negative rate in the extended prospective TATTOO trial evaluating targeted axillary dissection by carbon tattooing in clinically node-positive breast cancer patients receiving neoadjuvant systemic therapyJana de Boniface, Jan Frisell, Thorsten Kühn, et al.
Pageof 18